Close Menu

NEW YORK – Preventive genomics medicine company Veritas Intercontinental said on Thursday that it has completed a €5 million ($5.8 million) Series B financing round.

The round was led by Charme Capital Partners and Amadeus Capital Partners, who have invested in the Veritas Genetics spinoff firm since it was founded in 2018. They were joined in the Series B round by Stemar Capital Partners and entrepreneur Graham Snudden.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.